Collectively, our results suggest that the improvement in glucose metabolism observed in mice with IDDM co-administered leptin and liraglutide was due to enhanced leptin receptor signaling in the hypothalamus, independent of insulin receptor signaling, food intake, or BW changes. This evidence concerns the gene INSR and type 1 diabetes mellitus.